The 21st century has seen great strides in treatment for multiple myeloma, a cancer of the bone marrow once considered a death sentence. In fact, thanks to research by Dana-Farber scientists, this blood cancer that took the lives of Geraldine Ferraro and Leonard P. Zakim has become a chronic disease for many patients. Read more
Tag Archive for ClinicalTrials
Clinical trials are scientific studies in which new treatments – drugs, diagnostic procedures, and other therapies – are tested in people to find out if they are safe and effective. Nearly all cancer drugs in use today were tested in clinical trials. Read more
News about advances in cancer research and treatment appears almost daily. The pace at which new findings are reported, coupled with the complexity of the underlying science, can make it difficult to know which studies are truly significant and which are less so. It’s easy to become confused when reports seem to have varying conclusions.
Here are some tips for becoming a savvy consumer of cancer news. Read more
More than 18,000 cancer scientists from around the world are in Washington, D.C., this week for the annual meeting of the American Association for Cancer Research (AACR). The meeting serves as a forum for the presentation and discussion of the latest discoveries in cancer research.
The meeting coincides with the Rally for Medical Research, which was held Monday morning on the steps of the Carnegie Library in the nation’s capital.
Most people seek opinions from experts when it comes to important matters, such as finances, children’s education, or a major purchase.
Why not do so when it comes to your cancer treatment? Read more
When Jane Davis was diagnosed with breast cancer last July, she began learning as much as she could about her disease. Davis quickly discovered one of the most startling statistics about breast cancer: Up to 40 percent of women who have a lumpectomy require a second surgery. That’s because surgeons often cannot microscopically remove the entire tumor.
But Mehra Golshan, MD, FACS, director of Breast Surgical Services at Dana-Farber/Brigham and Women’s Cancer Center, is trying to change that with a phase I breast surgery pilot study. It’s the first of its kind in the world. Read more
For years, researchers have sought an avenue to deliver chemotherapy directly to retinoblastoma tumors – cancers of the retina of the eye, which primarily affect children under age 5. It turns out that the body itself offers just such a route. Read more
September is Ovarian Cancer Awareness Month and in recognition of that, we asked ovarian cancer survivor Margaret Winchester to share her story.
After being diagnosed with advanced (stage IIIC) ovarian cancer in 2008, I chose Dana-Farber for my care because I knew about the Institute’s cutting-edge approach to cancer care and research.
By Karen Lee Sobol
I recently learned that the word “patient” shares a Latin root with the word “compassion.”
Any one of us can become a patient, for a number of reasons. For me, hearing a diagnosis of Waldenström’s macroglobulinemia flipped a switch. I became a patient in a big way. Read more
Immunotherapy is one of the most technologically advanced yet basic forms of cancer treatment. It uses the body’s own defense mechanism, the immune system, to fight cancer.
Immunotherapy is probably most familiar to you in the form of vaccinations for the flu, polio, chicken pox, and other contagious diseases. In those cases, people are injected with a dead or weakened form of the virus responsible for the disease. That prompts the immune system to produce antibodies and white blood cells that ward off infection from the live virus.
For cancer prevention, two immune system-stimulating vaccines are now in use: one to protect against infection by the hepatitis B virus, which can give rise to liver cancer; and one to prevent infection by the human papillomavirus (HPV), which is linked to cervical cancer, some cancers of the head and neck, as well as anal and penile cancers.